Lukas Biomedical Inc. (TPEX:6814)

Lukas Biomedical Revenue

In the year 2025, Lukas Biomedical had annual revenue of 179.49M TWD, down -5.44%. Lukas Biomedical had revenue of 91.58M in the half year ending December 31, 2025, a decrease of -22.10%.

• Revenue: 179.49M
• Revenue Growth: -5.44%
• P/S Ratio: 5.83
• Revenue / Employee: 2.06M
• Employees: 96
• Market Cap: 1.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	179.49M	-10.34M	-5.44%
Dec 31, 2024	189.83M	-42.01M	-18.12%
Dec 31, 2023	231.83M	47.05M	25.46%
Dec 31, 2022	184.79M	27.17M	17.24%
Dec 31, 2021	157.62M	-23.79M	-13.12%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 29, 2026

Data Sources Report a data error